Literature DB >> 10602007

Memory phenotype CD8(+) T cells persist in livers of mice protected against malaria by immunization with attenuated Plasmodium berghei sporozoites.

M Guebre-Xabier1, R Schwenk, U Krzych.   

Abstract

Natural exposure to Plasmodium parasites induces short-lived protective immunity. In contrast, exposure to radiation-attenuated sporozoites (gamma spz) promotes long-lasting protection that is in part mediated by CD8(+) T cells that target exoerythrocytic stage antigens. The mechanisms underlying the maintenance of long-lasting protection are currently unclear. The liver is a repository of Plasmodium antigens and may support the development and / or homing of memory T cells. While activated CD8(+) T cells are presumed to die in the liver, the fate of anti-Plasmodium CD8(+) T cells remains unknown. We propose that inflammatory conditions in the liver caused by Plasmodium parasites may allow some effector CD8(+) T cells to survive and develop into memory cells. To support this hypothesis, in this initial study we demonstrate that liver mononuclear cells from P. berghei gamma spz-immune mice transferred protection to naive recipients and moreover, that CD4(+) and CD8(+) T cells responded to Plasmodium antigens by up-regulating activation / memory markers. While CD4(+) T cells under went a transient activation following immunization with gamma spz, CD8(+) T cells expanded robustly after spz challenge and exhibited stable expression of CD44(hi) and CD45RB(lo) during protracted protection. These results establish a key role for intrahepatic T cells in long-lasting protection against malaria.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10602007     DOI: 10.1002/(SICI)1521-4141(199912)29:12<3978::AID-IMMU3978>3.0.CO;2-0

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  25 in total

1.  Immunization with genetically attenuated P52-deficient Plasmodium berghei sporozoites induces a long-lasting effector memory CD8+ T cell response in the liver.

Authors:  Bruno Douradinha; Melissa van Dijk; Geert-Jan van Gemert; Shahid M Khan; Chris J Janse; Andy P Waters; Robert W Sauerwein; Adrian Jf Luty; Bruno Silva-Santos; Maria M Mota; Sabrina Epiphanio
Journal:  J Immune Based Ther Vaccines       Date:  2011-10-17

2.  Parasite load stemming from immunization route determines the duration of liver-stage immunity.

Authors:  Hardik Patel; Nouf Althubaiti; Rajesh Parmar; Naveen Yadav; Urja Joshi; Rajeev K Tyagi; Urszula Krzych; Sarat K Dalai
Journal:  Parasite Immunol       Date:  2019-04-04       Impact factor: 2.280

3.  Why functional pre-erythrocytic and bloodstage malaria vaccines fail: a meta-analysis of fully protective immunizations and novel immunological model.

Authors:  D Lys Guilbride; Pawel Gawlinski; Patrick D L Guilbride
Journal:  PLoS One       Date:  2010-05-19       Impact factor: 3.240

4.  Genetically attenuated Plasmodium berghei liver stages persist and elicit sterile protection primarily via CD8 T cells.

Authors:  Ann-Kristin Mueller; Martina Deckert; Kirsten Heiss; Kristin Goetz; Kai Matuschewski; Dirk Schlüter
Journal:  Am J Pathol       Date:  2007-07       Impact factor: 4.307

5.  Malaria protection in beta 2-microglobulin-deficient mice lacking major histocompatibility complex class I antigens: essential role of innate immunity, including gammadelta T cells.

Authors:  Tomoyo Taniguchi; Saoko Tachikawa; Yasuhiro Kanda; Toshihiko Kawamura; Chikako Tomiyama-Miyaji; Changchun Li; Hisami Watanabe; Hiroho Sekikawa; Toru Abo
Journal:  Immunology       Date:  2007-10-03       Impact factor: 7.397

6.  Short-lived effector CD8 T cells induced by genetically attenuated malaria parasite vaccination express CD11c.

Authors:  Laura A Cooney; Megha Gupta; Sunil Thomas; Sebastian Mikolajczak; Kimberly Y Choi; Claire Gibson; Ihn K Jang; Sam Danziger; John Aitchison; Malcolm J Gardner; Stefan H I Kappe; Ruobing Wang
Journal:  Infect Immun       Date:  2013-08-26       Impact factor: 3.441

Review 7.  Immunity to liver stage malaria: considerations for vaccine design.

Authors:  Andrew W Taylor-Robinson
Journal:  Immunol Res       Date:  2003       Impact factor: 2.829

Review 8.  Pre-erythrocytic malaria vaccines: identifying the targets.

Authors:  Patrick E Duffy; Tejram Sahu; Adovi Akue; Neta Milman; Charles Anderson
Journal:  Expert Rev Vaccines       Date:  2012-10       Impact factor: 5.217

9.  Memory CD8 T cells specific for plasmodia liver-stage antigens maintain protracted protection against malaria.

Authors:  Urszula Krzych; Sarat Dalai; Stasya Zarling; Alexander Pichugin
Journal:  Front Immunol       Date:  2012-12-10       Impact factor: 7.561

10.  Protective antibody and CD8+ T-cell responses to the Plasmodium falciparum circumsporozoite protein induced by a nanoparticle vaccine.

Authors:  Stephen A Kaba; Margaret E McCoy; Tais A P F Doll; Clara Brando; Qin Guo; Debleena Dasgupta; Yongkun Yang; Christian Mittelholzer; Roberta Spaccapelo; Andrea Crisanti; Peter Burkhard; David E Lanar
Journal:  PLoS One       Date:  2012-10-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.